Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C4BPA pseudogene 2 (C4BPAP2) is a pseudogene closely related to the protein-coding complement component 4 binding protein alpha (C4BPA) gene, which is involved in regulation of the classical pathway of the complement system—a critical part of immune response and inflammation. However, as a pseudogene, C4BPAP2 itself does not code for a functional protein and is currently not considered biologically active, nor is it a therapeutic target, nor associated with any known disease, mechanism of action, or biomarker[2][4]. The more widely studied functional gene in this family (C4BPA) has roles in coagulation, immunity, and lipid metabolism regulation, but C4BPAP2 does not play these roles[2][4]. There are no known drugs or therapies that target C4BPAP2, and no evidence for clinical relevance, disease association, or involvement in biological pathways beyond its status as a genomic pseudogene. It is also not a canonical target for drug discovery or clinical biomarkers. If you are seeking information on a therapeutically relevant target, the functional gene C4BPA (complement component 4 binding protein alpha) is the appropriate entity and not the pseudogene C4BPAP2[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C4BPA pseudogene 2 (C4BPAP2).